[Small dense LDL concentration is closely associated with serum apolipoprotein B, comparisons of non-LDL cholesterol or LDL cholesterol]. 2006

Toshiyuki Hayashi, and Tsutomu Hirano, and Tomomi Shiobara, and Toshiaki Suguro, and Mitsuru Adachi
First Department of Internal Medicine, Showa University School of Medicine, Tokyo.

Small dense low-density lipoprotein (sd LDL) is more atherogenic than large buoyant (lb) LDL, which is relatively high in particle number (as estimated by apolipoprotein [apo] B) and poor in cholesterol (C) content. Because recent epidemiological studies have shown that serum apo B is a stronger predictor of the risk of coronary heart disease (CHD) than LDL-C, we assumed that this strong predictive power of apo B for CHD is attributable to a close association with sd LDL concentration. On the other hand, non-HDL-C has been proposed as an integrated CHD risk marker containing all atherogenic apo B-containing lipoproteins. We examined which apo B or non-HDL-C is superior marker in reflecting sd-LDL particles. Eighty-one subjects with dyslipidemia were studied. Sd LDL (density, 1.044 approximately .063g/ml) and large buoyant LDL (density, 1.019 approximately 1.044g/ml) were separated by the ultracentrifugation method and LDL size was measured by gradient gel electrophoresis. LDL-C, non-HDL-C, and apo B were highly associated with each other(r=0.78 approximately 0.87), and all were associated with C, apo B, and TG in sd-LDL. However, multivariate regression analysis revealed that only apo B was constantly and independently associated with sd-LDL concentrations. Mean LDL diameter was negatively associated with apo B but not with non-HDL-C. These results suggest that apo B is superior to non-HDL-C in reflecting a potent atherogenic lipoprotein, sd-LDL, which may explain a potent predictive power of apo B for CHD.

UI MeSH Term Description Entries
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008078 Cholesterol, LDL Cholesterol which is contained in or bound to low density lipoproteins (LDL), including CHOLESTEROL ESTERS and free cholesterol. LDL Cholesterol,Cholesteryl Linoleate, LDL,LDL Cholesteryl Linoleate,Low Density Lipoprotein Cholesterol,beta-Lipoprotein Cholesterol,Cholesterol, beta-Lipoprotein,beta Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

Toshiyuki Hayashi, and Tsutomu Hirano, and Tomomi Shiobara, and Toshiaki Suguro, and Mitsuru Adachi
December 2009, Atherosclerosis,
Toshiyuki Hayashi, and Tsutomu Hirano, and Tomomi Shiobara, and Toshiaki Suguro, and Mitsuru Adachi
July 2000, Annals of clinical biochemistry,
Toshiyuki Hayashi, and Tsutomu Hirano, and Tomomi Shiobara, and Toshiaki Suguro, and Mitsuru Adachi
April 2012, Rinsho byori. The Japanese journal of clinical pathology,
Toshiyuki Hayashi, and Tsutomu Hirano, and Tomomi Shiobara, and Toshiaki Suguro, and Mitsuru Adachi
June 2022, Biomedicines,
Toshiyuki Hayashi, and Tsutomu Hirano, and Tomomi Shiobara, and Toshiaki Suguro, and Mitsuru Adachi
December 2010, Journal of internal medicine,
Toshiyuki Hayashi, and Tsutomu Hirano, and Tomomi Shiobara, and Toshiaki Suguro, and Mitsuru Adachi
August 2023, Journal of the American Heart Association,
Toshiyuki Hayashi, and Tsutomu Hirano, and Tomomi Shiobara, and Toshiaki Suguro, and Mitsuru Adachi
February 2010, Clinica chimica acta; international journal of clinical chemistry,
Toshiyuki Hayashi, and Tsutomu Hirano, and Tomomi Shiobara, and Toshiaki Suguro, and Mitsuru Adachi
September 2007, Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology,
Toshiyuki Hayashi, and Tsutomu Hirano, and Tomomi Shiobara, and Toshiaki Suguro, and Mitsuru Adachi
August 2003, Clinica chimica acta; international journal of clinical chemistry,
Toshiyuki Hayashi, and Tsutomu Hirano, and Tomomi Shiobara, and Toshiaki Suguro, and Mitsuru Adachi
January 2019, Nutrition & metabolism,
Copied contents to your clipboard!